TAVR Patient Populations Not Served with Current Indications - Michael Reardon, MD

↳ This is a section part of Moment: CRT 2016 Valve & Structural - Percutaneous Aortic Valves: Knowledge Gaps in a Maturing Technology

Add this Moment to your Passport

Learn from this moment and keep it forever.
add to passport
$19.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Preview

Summary

TAVR Patient Populations Not Served with Current Indications presented by Michael Reardon, MD at CRT 2016

Add this Moment to your Passport

Learn from this moment and keep it forever.
add to passport
$19.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Target Audience

  • Interventional Cardiologists 
  • Structural Heart Specialists 
  • Interventional Fellows 
  • Cardiac Surgeons 

Session Name: Percutaneous Aortic Valves: Knowledge Gaps in a Maturing Technology

Track: Track: CRT Valve & Structural

Learning Objectives

  • Update in advances/best practice in Valve & Structural procedures

Other Components in this Moment

Overview
TAVR Patient Populations Not Served with Current Indications - Michael Reardon, MD
Update to Leaflet Thrombosis Findings - Rajendra Makkar, MD, FSCAI
TAVR Bioprosthesis Thrombosis: Have Findings Changed Clinical Practice? - Azeem Latib, MD
Anticoagulation Post-TAVR: How Should We Find the Optimal Protocol? - Azeem Latib, MD
How to Assess Cognitive Impairment in Patients Undergoing TAVR - Ronald Lazar, PhD, FAHA
Surrogates Endpoint: Is it Sufficient to Support Approval and Clinical Use of Cerebral Embolic Protection Devices - Michael Mack, MD
Loading Simple Education